title: Outlook: finding improved medicines: the role of academic-industrial collaboration.
abstract: This paper reviews models of academic-pharmaceutical industry collaboration and debates the value of such partnerships so that those contemplating an alliance can reflect a priori on the purpose, nature and process that will provide a constructive outcome. The scope is confined to the biomedical discipline, because collaborations in other fields, such as physics and engineering, have not suffered as a result of the concerns associated with biomedicine.
authors.affiliation: Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute, Commercial Road, Melbourne 3004, Australia. jaye.chin-dusting@baker.edu.au
authors.forename: Jaye
authors.initials: J
authors.lastname: Chin-Dusting
authors.forename: Jacques
authors.initials: J
authors.lastname: Mizrahi
authors.forename: Garry
authors.initials: G
authors.lastname: Jennings
authors.forename: Desmond
authors.initials: D
authors.lastname: Fitzgerald
mesh_terms: D000046:Academic Medical Centers / Q000191:economics / Q000458:organization & administration*; D035843:Biomedical Research / Q000191:economics / Q000458:organization & administration*; D003299:Cooperative Behavior; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D007373:Interinstitutional Relations; D012109:Research Support as Topic